ScholarIQanswers from OpenAlex

Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity

PaperCitations, authors & open-access status

Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity have?

ScholarIQcitation count

Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity has 160 citations in the OpenAlex counts ScholarIQ stores.

When was Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity published?

ScholarIQyear

Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity has 2013 year in the ScholarIQ index.

What is the open-access status of Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity?

ScholarIQoa status

Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity has bronze oa status in the ScholarIQ index.

What is the DOI of Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity?

ScholarIQdoi

The DOI for Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity is on the source record.

What is the PMID of Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity?

ScholarIQpmid

The PMID for Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity is on the source record.

What is the OpenAlex record for Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity?

ScholarIQopenalex

The OpenAlex for Repurposing the antimycotic drug flucytosine for suppression of <i>Pseudomonas aeruginosa</i> pathogenicity is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial